Enman J, Rova U, Berglund KA: Quantification of the bioactive compound eritadenine in selected strains of shiitake mushroom (Lentinus edodes). J Agric Food Chem. 2007 Feb 21;55(4):1177-80.
Gordon M, Bihari B, Goosby E, Gorter R, Greco M, Guralnik M, Mimura T,Rudinicki V, Wong R, Kaneko Y: A placebocontrolled trial of the immune modulator, lentinan,in HIVpositive patients: a phase I/II trial. J Med. 1998;29(5-6):305-30.
Jennemann R, Sandhoff R, Gröne HJ, Wiegandt H: Human heterophile antibodiesrecognizing distinct carbohdrate epitopes on basidiolipids from differentmushrooms. Immunol Invest. 2001 May;30(2):115-29.
Kuznetsov OIu, Mil`kova EV, Sosnina AE, Sotnikova NIu: Antimicrobial actionof Lentinus edodes juice on human microflora. Zh Mikrobiol Epidemiol Immunobiol. 2005Jan-Feb;(1):80-2.
Ng ML, Yap AT: Inhibition of human colon carcinomadevelopment by lentinan from shiitake mushrooms (Lentinus edodes). J Altern ComplementMed. 2002 Oct;8(5):581-9.
Ngai PH, Ng TB: Lentin, a novel and potentantifungal protein from shitake mushroom with inhibitoryeffects on activity of human mmunodeficiency virus-1 reverse transcriptase andProliferation of leukemia cells.Life Sci. 2003 Nov 14;73(26):3363-74.
Shen J, Ren H,Tomiyama-Miyaji C, Suga Y, Suga T, Kuwano Y, Iiai T, Hatakeyama K, Abo T: Potentiation ofintestinal immunity by micellary mushroom extracts. Biomed Res. 2007 Apr;28(2):71-7.
Shimada S, Komamura K, Kumagai H,Sakurai H: Inhibitory activity of shiitake flavor against platelet aggregation. Biofactors.2004;22(1-4):177-9.
Quelle MRC Austria
1) Shiitake (Lentinusedodes) Wasser SP. Encyclopedia of Dietary Supplements. 2005
2) Lentin, a novel andpotent antifungal protein from shitake mushroom with inhibitory effects onactivity of human immunodeficiency virus-1 reverse transcriptase andproliferation of leukemia cells. Ngai P.H, Ng T.B. Life Sci.2003;73(26):3363-74.
3) Shiitake dermatitis nowoccurs in France. Hérault M, Waton J, Bursztejn A.C, Schmutz J.L, Barbaud A.Ann Dermatol Venereol. 2010;137(4):290-3.
4) Shiitake dermatitis:flagellate dermatitis after eating mushrooms. Hautarzt. Haas N, Vogt R, SterryW. 2001;52(2):132-5
5) Individual patientbased meta-analysis of lentinan for unresectable/recurrent gastric cancer. ObaK, Kobayashi M, Matsui T, Kodera Y, Sakamoto J. Anticancer Res.2009;29(7):2739-45.
6) Effects of lentinan inadvanced or recurrent cases of gastric, colorectal, and breast cancer. TaguchiT. Gan To Kagaku Ryoho. 1983;10(2 Pt 2):387-93.
7) Effect of lentinan foradvanced prostate carcinoma. Tari K, Satake I, Nakagomi K, Ozawa K, Oowada F,Higashi Y, Negishi T, Yamada T, Saito H, Yoshida K. Hinyokika Kiyo.1994;40(2):119-23.
8) Inhibition of humancolon carcinoma development by lentinan from shiitake mushrooms (Lentinusedodes). Ng M.L, Yap A.T. J Altern Complement Med. 2002;8(5):581-9.
9) The medicinal benefitsof Lentinan (β-1, 3-D glucan) from Lentinus edodes (Berk.) singer (ShiitakeMushroom) through oral administration. Yap A.T, Ng M.H. Int J Med Mushr.2005;7(12):170
10) Production of the bioactivecompound eritadenine by submerged cultivation of shiitake (Lentinus edodes)mycelia. Enman J, Hodge D, Berglund K.A, Rova U. J Agric Food Chem.2008;56(8):2609-12.
11) Quantification of thebioactive compound eritadenine in selected strains of shiitake mushroom(Lentinus edodes). Enman J, Rova U, Berglund K.A. J Agric Food Chem.2007;55(4):1177-80.
12) Yamada T, Oinuma T,Niihashi M, Mitsumata M, Fujioka T, Hasegawa K, Nagaoka H, Itakura H: Effectsof Lentinus edodes Lexikon mycelia on dietary-induced atheroscleroticinvolvement in rabbit aorta. J Atheroscler Thromb. 2002;9(3):149-56..
13) Kabir Y, Yamaguchi M,Kimura S: Effect of shiitake (Lentinus edodes Lexikon) and maitake (Grifolafrondosa Lexikon) mushrooms on blood pressure and plasma lipids ofspontaneously hypertensive rats. J Nutr Sci Vitaminol (Tokyo). 1987Oct;33(5):341-6
14) Shimada S, Komamura K,Kumagai H, Sakurai H: Inhibitory activity of shiitake flavor against plateletaggregation. Biofactors. 2004;22(1-4):177-9.